Oncology

Neuroendocrine tumors (NETs) have become significantly more common over the past two decades. Between 2000 and 2018, the age-adjusted incidence rose from 4.9 to 8.2 cases per 100,000 people, with the sharpest increases seen in grade 1 tumors, early-stage cases, and tumors of the appendix. Alarmingly, the mortality rate grew more than...

Bladder cancer is a major global health concern, ranking among the top ten most common cancers worldwide. It affects both sexes but occurs more frequently in men, especially those over the age of 55. According to the U.S. National Cancer Institute, approximately 84,870 new cases of bladder cancer were diagnosed in 2024 in the United...

Bladder cancer is one of the most common cancers worldwide, affecting both men and women, though men are significantly more likely to be diagnosed. According to the U.S. National Cancer Institute, an estimated 84,870 new cases of bladder cancer have been diagnosed in the United States in 2024 alone, with approximately 17,420 related...

Ovarian cancer remains one of the most challenging malignancies in gynecologic oncology. Often diagnosed at an advanced stage, it is the fifth leading cause of cancer-related death among women in the Western world. According to the American Cancer Society, over 20,000 new cases of ovarian cancer will be diagnosed in the...

Renal cell carcinoma (RCC) accounts for approximately 90% of all kidney cancers and remains one of the ten most common cancers worldwide. In 2022 alone, more than 435,000 new cases were diagnosed globally, with over 156,000 deaths attributed to the disease. The incidence has been steadily increasing, particularly in high-income...

Liver cancer remains one of the most pressing global health challenges of the 21st century. It is the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for the vast majority of cases. According to the Global Cancer Observatory, over 900,000 new liver cancer cases were diagnosed in 2022 alone...

Multiple myeloma is a malignant blood disorder that affects plasma cells - white blood cells responsible for producing antibodies. This type of cancer typically develops in the bone marrow and can lead to bone damage, anemia, kidney failure, and a weakened immune system. Although it remains incurable, the last decade has brought significant...

Non-small cell lung cancer affects 85% of lung cancer patients, with stage III-IV cases having less than 5% five-year survival rates. While traditional treatments help only 30% of selected patients, innovative dendritic cell immunotherapy shows 50-65% effectiveness rates in clinical studies. These "immune system generals" train your body to fight...